The Optibrium team works at the forefront of decision-analysis and predictive modelling research, developing innovative products that enhance the efficiency and productivity of drug discovery.
StarDrop™ is a complete package of fully integrated, elegant software for small molecule design, optimisation and data analysis.
Keep up to date
News & Events
Optibrium appoints Dr Rae Lawrence as Director of Software Development • New role will drive development of AI-based drug discovery software solutions and lead development team expansion CAMBRIDGE, UK, 8 February 2021 – Optibrium™, a developer of software for ... Read More
Optibrium Raises Investment to Advance Computer-Aided Drug Discovery • Investment by Kester Capital will drive commercial growth and the development of new products to improve speed, efficiency, and productivity of the discovery process CAMBRIDGE, UK, 8 ... Read More
Optibrium Enhances Compound Design Strategies in Major Upgrade to StarDrop Software • New features include reaction-based library enumeration for novel molecule generation and optimisation • AI-integrated with seamless interface to Optibrium’s Artificial Intelligence ... Read More
Thursday 29 April, 4.00pm (UK)
Gerhard Ecker and Matt Segall
Founded in 2009, Optibrium continues to develop new products and research novel technologies to improve the efficiency and productivity of drug discovery. Optibrium works closely with its broad range of customers and collaborators that include leading global pharma, agrochemical and flavouring companies, biotechs and academic groups.
Got an Enquiry?
Get In Touch
If you are interested in finding out more about Optibrium or any of our products or services, please do not hesitate to contact us using the contact form. Further details on our office locations and other contact details can be found on our Contact page.